Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 4/2019

21.01.2019 | Head & Neck

Outcomes of salvage surgery for the oropharynx and larynx: a contemporary experience in a UK Cancer Centre

verfasst von: Ashley Hay, Ricard Simo, Gillian Hall, Selvam Tharavai, Richard Oakley, Alastair Fry, Luke Cascarini, Mary Lei, Teresa Guerro-Urbano, Jean-Pierre Jeannon

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The purpose of this study was to review our recent experience of salvage surgery, comparing larynx and oropharynx recurrence patterns.

Methods

A single centre, retrospective review of salvage surgery for recurrent head and neck cancer including patients between 2008 and 2016.

Results

61 patients were identified, 36 underwent salvage laryngectomy and 25 received oropharyngeal resections. The median overall survival of oropharyngeal recurrent tumors was 26 months (95% CI 15–118 months) and for laryngeal tumors was 23 months (95% CI 11–38 months), p = 0.1008. There was a significant overall survival benefit in patients with negative resection margin. The median survival in the negative margin group was 38 months (95% CI 25–108 months) compared to the positive margin group, 9 months (95% CI 5–15 months), p < 0.0001.

Conclusion

Survival results following surgical salvage in the larynx and oropharynx appear to be similarly poor. Those patients with clear margins appear to have a significantly better prognosis.
Literatur
1.
Zurück zum Zitat Chen AY, Fedewa S, Zhu J (2011) Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985–2007. Arch Otolaryngol Head Neck Surg 137(10):1017–1024CrossRefPubMed Chen AY, Fedewa S, Zhu J (2011) Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985–2007. Arch Otolaryngol Head Neck Surg 137(10):1017–1024CrossRefPubMed
2.
Zurück zum Zitat Maddox PT, Davies L (2012) Trends in total laryngectomy in the era of organ preservation: a population-based study. Otolaryngol Head Neck Surg 147(1):85–90CrossRefPubMed Maddox PT, Davies L (2012) Trends in total laryngectomy in the era of organ preservation: a population-based study. Otolaryngol Head Neck Surg 147(1):85–90CrossRefPubMed
3.
Zurück zum Zitat Chen AY, Schrag N, Hao Y, Stewart A, Ward E (2007) Changes in treatment of advanced oropharyngeal cancer, 1985–2001. Laryngoscope 117(1):16–21CrossRefPubMed Chen AY, Schrag N, Hao Y, Stewart A, Ward E (2007) Changes in treatment of advanced oropharyngeal cancer, 1985–2001. Laryngoscope 117(1):16–21CrossRefPubMed
4.
Zurück zum Zitat Chen AY, Zhu J, Fedewa S (2014) Temporal trends in oropharyngeal cancer treatment and survival: 1998–2009. Laryngoscope 124(1):131–138CrossRefPubMed Chen AY, Zhu J, Fedewa S (2014) Temporal trends in oropharyngeal cancer treatment and survival: 1998–2009. Laryngoscope 124(1):131–138CrossRefPubMed
5.
Zurück zum Zitat Lyhne NM, Johansen J, Kristensen CA, Andersen E, Primdahl H, Andersen LJ et al (2016) Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent—a population based study from the DAHANCA group. Radiother Oncol 118(2):257–266CrossRefPubMed Lyhne NM, Johansen J, Kristensen CA, Andersen E, Primdahl H, Andersen LJ et al (2016) Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent—a population based study from the DAHANCA group. Radiother Oncol 118(2):257–266CrossRefPubMed
6.
Zurück zum Zitat Bird T, De Felice F, Michaelidou A, Thavaraj S, Jeannon JP, Lyons A et al (2017) Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma—a European singleinstitution analysis. Clin Otolaryngol 42(1):115–122CrossRefPubMed Bird T, De Felice F, Michaelidou A, Thavaraj S, Jeannon JP, Lyons A et al (2017) Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma—a European singleinstitution analysis. Clin Otolaryngol 42(1):115–122CrossRefPubMed
7.
Zurück zum Zitat Zafereo ME, Hanasono MM, Rosenthal DI, Sturgis EM, Lewin JS, Roberts DB et al (2009) The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer 115(24):5723–5733CrossRefPubMed Zafereo ME, Hanasono MM, Rosenthal DI, Sturgis EM, Lewin JS, Roberts DB et al (2009) The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer 115(24):5723–5733CrossRefPubMed
8.
Zurück zum Zitat Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG (2014) Decision making in the management of recurrent head and neck cancer. Head Neck 36(1):144–151CrossRefPubMed Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG (2014) Decision making in the management of recurrent head and neck cancer. Head Neck 36(1):144–151CrossRefPubMed
9.
Zurück zum Zitat Goodwin WJ (2000) Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110(3 Pt 2 Suppl 93):1–18CrossRefPubMed Goodwin WJ (2000) Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110(3 Pt 2 Suppl 93):1–18CrossRefPubMed
10.
Zurück zum Zitat Kowalski LP, Carvalho AL (2000) Natural history of untreated head and neck cancer. Eur J Cancer 36(8):1032–1037CrossRefPubMed Kowalski LP, Carvalho AL (2000) Natural history of untreated head and neck cancer. Eur J Cancer 36(8):1032–1037CrossRefPubMed
11.
Zurück zum Zitat Ganly I, Patel S, Matsuo J, Singh B, Kraus D, Boyle J et al (2005) Postoperative complications of salvage total laryngectomy. Cancer 103(10):2073–2081CrossRefPubMed Ganly I, Patel S, Matsuo J, Singh B, Kraus D, Boyle J et al (2005) Postoperative complications of salvage total laryngectomy. Cancer 103(10):2073–2081CrossRefPubMed
12.
Zurück zum Zitat Stoeckli SJ, Pawlik AB, Lipp M, Huber A, Schmid S (2000) Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg 126(12):1473–1477CrossRefPubMed Stoeckli SJ, Pawlik AB, Lipp M, Huber A, Schmid S (2000) Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg 126(12):1473–1477CrossRefPubMed
13.
Zurück zum Zitat McLaughlin MP, Parsons JT, Fein DA, Stringer SP, Cassisi NJ, Mendenhall WM et al (1996) Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx. Head Neck 18(3):229–235CrossRefPubMed McLaughlin MP, Parsons JT, Fein DA, Stringer SP, Cassisi NJ, Mendenhall WM et al (1996) Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx. Head Neck 18(3):229–235CrossRefPubMed
14.
Zurück zum Zitat Kano S, Homma A, Hayashi R, Kawabata K, Yoshino K, Iwae S et al (2013) Salvage surgery for recurrent oropharyngeal cancer after chemoradiotherapy. Int J Clin Oncol 18(5):817–823CrossRefPubMed Kano S, Homma A, Hayashi R, Kawabata K, Yoshino K, Iwae S et al (2013) Salvage surgery for recurrent oropharyngeal cancer after chemoradiotherapy. Int J Clin Oncol 18(5):817–823CrossRefPubMed
15.
Zurück zum Zitat Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35CrossRefPubMedPubMedCentral Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301CrossRefPubMedPubMedCentral Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Paleri V, Roland N (2016) Introduction to the United Kingdom national multidisciplinary guidelines for head and neck cancer. J Laryngol Otol 130(S2):S3–S4CrossRefPubMedCentral Paleri V, Roland N (2016) Introduction to the United Kingdom national multidisciplinary guidelines for head and neck cancer. J Laryngol Otol 130(S2):S3–S4CrossRefPubMedCentral
18.
Zurück zum Zitat American Joint Committee on C, Edge SB, American Joint Committee on C (2010) AJCC cancer staging manual. 7th edn, vol xiv. Springer, New York, p 648 ill., port. ; 28 cm. + 1 CD-ROM (4 3/4 in.) pCrossRef American Joint Committee on C, Edge SB, American Joint Committee on C (2010) AJCC cancer staging manual. 7th edn, vol xiv. Springer, New York, p 648 ill., port. ; 28 cm. + 1 CD-ROM (4 3/4 in.) pCrossRef
19.
Zurück zum Zitat Guo T, Qualliotine JR, Ha PK, Califano JA, Kim Y, Saunders JR et al (2015) Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer. Cancer 121(12):1977–1984CrossRefPubMed Guo T, Qualliotine JR, Ha PK, Califano JA, Kim Y, Saunders JR et al (2015) Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer. Cancer 121(12):1977–1984CrossRefPubMed
20.
Zurück zum Zitat Eckardt A, Barth EL, Kokemueller H, Wegener G (2004) Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period. Oral Oncol 40(4):427–432CrossRefPubMed Eckardt A, Barth EL, Kokemueller H, Wegener G (2004) Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period. Oral Oncol 40(4):427–432CrossRefPubMed
21.
Zurück zum Zitat Frakes JM, Strom T (2016) Detection of recurrence in HPV associated oropharynx squamous cell carcinoma. In: Presented at: 2016 multidisciplinary head and neck cancer symposium; February 18–20, 2016; Scottsdale, AZ. Abstract 62016 Frakes JM, Strom T (2016) Detection of recurrence in HPV associated oropharynx squamous cell carcinoma. In: Presented at: 2016 multidisciplinary head and neck cancer symposium; February 18–20, 2016; Scottsdale, AZ. Abstract 62016
22.
Zurück zum Zitat Yao M, Smith RB, Hoffman HT, Funk GF, Lu M, Menda Y et al (2009) Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. Int J Radiat Oncol Biol Phys 74(1):9–14CrossRefPubMed Yao M, Smith RB, Hoffman HT, Funk GF, Lu M, Menda Y et al (2009) Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. Int J Radiat Oncol Biol Phys 74(1):9–14CrossRefPubMed
23.
Zurück zum Zitat Bird T, Barrington S, Thavaraj S, Jeannon JP, Lyons A, Oakley R et al (2016) (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging 43(7):1239–1247CrossRefPubMed Bird T, Barrington S, Thavaraj S, Jeannon JP, Lyons A, Oakley R et al (2016) (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging 43(7):1239–1247CrossRefPubMed
24.
Zurück zum Zitat Bachar GY, Goh C, Goldstein DP, O’Sullivan B, Irish JC (2010) Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy. Eur Arch Otorhinolaryngol 267(2):295–301CrossRefPubMed Bachar GY, Goh C, Goldstein DP, O’Sullivan B, Irish JC (2010) Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy. Eur Arch Otorhinolaryngol 267(2):295–301CrossRefPubMed
25.
Zurück zum Zitat Nichols AC, Kneuertz PJ, Deschler DG, Lin DT, Emerick KS, Clark JR et al (2011) Surgical salvage of the oropharynx after failure of organ-sparing therapy. Head Neck 33(4):516–524CrossRefPubMed Nichols AC, Kneuertz PJ, Deschler DG, Lin DT, Emerick KS, Clark JR et al (2011) Surgical salvage of the oropharynx after failure of organ-sparing therapy. Head Neck 33(4):516–524CrossRefPubMed
26.
Zurück zum Zitat Patel SN, Cohen MA, Givi B, Dixon BJ, Gilbert RW, Gullane PJ et al (2016) Salvage surgery for locally recurrent oropharyngeal cancer. Head Neck 38(Suppl 1):E658–E664CrossRefPubMed Patel SN, Cohen MA, Givi B, Dixon BJ, Gilbert RW, Gullane PJ et al (2016) Salvage surgery for locally recurrent oropharyngeal cancer. Head Neck 38(Suppl 1):E658–E664CrossRefPubMed
27.
Zurück zum Zitat Hamoir M, Holvoet E, Ambroise J, Lengele B, Schmitz S (2017) Salvage surgery in recurrent head and neck squamous cell carcinoma: Oncologic outcome and predictors of disease free survival. Oral Oncol 67:1–9CrossRefPubMed Hamoir M, Holvoet E, Ambroise J, Lengele B, Schmitz S (2017) Salvage surgery in recurrent head and neck squamous cell carcinoma: Oncologic outcome and predictors of disease free survival. Oral Oncol 67:1–9CrossRefPubMed
Metadaten
Titel
Outcomes of salvage surgery for the oropharynx and larynx: a contemporary experience in a UK Cancer Centre
verfasst von
Ashley Hay
Ricard Simo
Gillian Hall
Selvam Tharavai
Richard Oakley
Alastair Fry
Luke Cascarini
Mary Lei
Teresa Guerro-Urbano
Jean-Pierre Jeannon
Publikationsdatum
21.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 4/2019
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-019-05295-x

Weitere Artikel der Ausgabe 4/2019

European Archives of Oto-Rhino-Laryngology 4/2019 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.